Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

被引：0
|
作者：
Seam, Pamela [1 ]
Mahat, Upendra [2 ]
Bouchkouj, Najat [2 ]
Sharma, Poornima [2 ]
Peredo-Pinto, Helka [2 ]
Elmacken, Mona [2 ]
Kaushal, Megha [2 ]
Jia, Yuxia [2 ]
Wang, Shu [3 ]
Xu, Zhiheng [3 ]
Kasamon, Yvette [1 ]
Kanaparu, Bindu [1 ]
Richardson, Nicholas [1 ]
Gormley, Nicole [1 ]
机构：
[1] US FDA, Div Hematol Malignancies 2, Ctr Drug Evaluat & Res CDER, Silver Spring, MD USA
[2] US FDA, Div Clin Evaluat Hematol, Ctr Biol Evaluat & Res CBER, Off Therapeut Prod OTP, Silver Spring, MD USA
[3] US FDA, Ctr Drug Evaluat & Res CDER, Off Biostat, Silver Spring, MD USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186544
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Utilization of Chimeric Antigen Receptor T-cell Therapy in Adults
    Dudley, Channing Vail
    Baer, Brittney
    Simons, Rhea Micci
    SEMINARS IN ONCOLOGY NURSING, 2019, 35 (05)
  • [32] Radiotherapy for Relapse after Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies
    Hubbeling, H. G.
    Silverman, E. A.
    Tomas, A. Alarcon
    Tringale, K. R.
    Wijetunga, N. A.
    Hajj, C.
    Mailankody, S.
    Batlevi, C. L.
    Dahi, P. B.
    Giralt, S. A.
    Lin, R. J.
    Park, J. H.
    Scordo, M.
    Sauter, C. S.
    Shah, G. L.
    Perales, M. A.
    Palomba, M. L.
    Shouval, R.
    Yahalom, J.
    Imber, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S56 - S57
  • [33] Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
    Wenjing Luo
    Chenggong Li
    Yinqiang Zhang
    Mengyi Du
    Haiming Kou
    Cong Lu
    Heng Mei
    Yu Hu
    BMC Cancer, 22
  • [34] Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
    Luo, Wenjing
    Li, Chenggong
    Zhang, Yinqiang
    Du, Mengyi
    Kou, Haiming
    Lu, Cong
    Mei, Heng
    Hu, Yu
    BMC CANCER, 2022, 22 (01)
  • [35] Racial disparities and inequity in clinical trials of chimeric antigen receptor T-cell therapy
    Thakur, Rahul Kumar
    Mehta, Ansh
    Vegivinti, Charan Thej Reddy
    Hammami, M. Bakri Bakri
    Adhikari, Biplov
    Subedi, Roshan
    Adhikari, Anurag
    Kumar, Abhishek
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
    Efficace, Fabio
    Cannella, Laura
    Sparano, Francesco
    Giesinger, Johannes M. M.
    Vignetti, Marco
    Baron, Frederic
    Bruera, Eduardo
    Luppi, Mario
    Platzbecker, Uwe
    HEMASPHERE, 2022, 6 (12): : E802
  • [37] Enrollment of Black Americans in Pivotal Clinical Trials Supporting Food and Drug Administration (FDA) Chimeric Antigen Receptor (CAR)-T Cell Therapy Approval in Hematological Malignancies
    Al Hadidi, Samer
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    Rhee, Fritsvan
    BLOOD, 2021, 138
  • [38] Resource Utilization Lady after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies
    Shah, Gunjan L.
    Park, Jae H.
    Sauter, Craig S.
    Duck, Elaine
    Halton, Elizabeth
    Palomba, Maria Lia
    Batlevi, Connie Lee
    Younes, Anas
    Geyer, Mark Blaine
    Smith, Eric L.
    Mailankody, Sham
    Mead, Elena
    Santomasso, Bianca
    Perales, Miguel-Angel
    Sabbatini, Paul
    Giralt, Sergio
    Brentjens, Renier J.
    Bach, Peter
    BLOOD, 2018, 132
  • [39] At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies
    Daniyan, Anthony F. O.
    Brentjens, Renier J.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (06) : 1255 - 1264
  • [40] Chimeric antigen receptor (CAR) t-cell therapy for thoracic malignancies (vol 13, pg 16, 2018)
    Kiesgen, S.
    Chicaybam, L.
    Chintala, N. K.
    Adusumilli, P. S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : 1229 - 1229
12345